Cargando…

Robotic surgery can be safely performed for patients and healthcare workers during COVID‐19 pandemic

OBJECTIVES: To investigate the safety of robotic surgery during COVID‐19 pandemic concerning new‐acquired COVID‐19 infections for patients and healthcare workers. PATIENTS: We performed a retrospective single‐centre cohort study of patients undergoing robotic surgery in initial period of COVID‐19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sparwasser, Peter, Brandt, Maximillian P., Haack, Maximillian, Dotzauer, Robert, Boehm, Katharina, Gheith, Mohammed Kamal, Mager, Rene, Jäger, Wolfgang, Ziebart, Alexander, Höfner, Thomas, Tsaur, Igor, Haferkamp, Axel, Borgmann, Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209902/ https://www.ncbi.nlm.nih.gov/pubmed/34050598 http://dx.doi.org/10.1002/rcs.2291

Ejemplares similares

Robotic surgery is safely performed for patients and healthcare workers during COVID-19 pandemic
por: Sparwasser, P., et al.
Publicado: (2020)

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic
por: Dotzauer, Robert, et al.
Publicado: (2020)

Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected
por: Duwe, Gregor, et al.
Publicado: (2023)

Telemedicine Online Visits in Urology During the COVID-19 Pandemic—Potential, Risk Factors, and Patients’ Perspective
por: Boehm, Katharina, et al.
Publicado: (2020)

First completely robot-assisted retroperitoneal nephroureterectomy with bladder cuff: a step-by-step technique
por: Sparwasser, P., et al.
Publicado: (2022)

High–Normal Preoperative Potassium Level Is Associated with Reduced 30–Day Morbidity and Shorter Hospital Stay after Radical Cystectomy
por: Borgmann, Hendrik, et al.
Publicado: (2022)

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology
por: Borgmann, Hendrik, et al.
Publicado: (2021)

Assessment of a novel smartglass-based point-of-care fusion approach for mixed reality-assisted targeted prostate biopsy: A pilot proof-of-concept study
por: Sparwasser, P., et al.
Publicado: (2022)

Robot-assisted simple prostatectomy versus open simple prostatectomy: a single-center comparison
por: Dotzauer, R., et al.
Publicado: (2020)

Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition
por: Börner, J. H., et al.
Publicado: (2023)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
por: Thomas, Christian, et al.
Publicado: (2016)

Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models
por: Haack, Maximilian, et al.
Publicado: (2023)

Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma—Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation
por: Duwe, Gregor, et al.
Publicado: (2023)

Virtual und Augmented Reality in der Urologie
por: Sparwasser, P., et al.
Publicado: (2021)

Utilization of surgical safety checklists by urological surgeons in Germany: a nationwide prospective survey
por: Borgmann, Hendrik, et al.
Publicado: (2015)

sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients
por: Tsaur, Igor, et al.
Publicado: (2015)

Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation
por: Duwe, Gregor, et al.
Publicado: (2023)

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
por: Haack, Maximilian, et al.
Publicado: (2022)

Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer
por: Tsaur, Igor, et al.
Publicado: (2015)

Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content
por: Salem, Johannes, et al.
Publicado: (2016)

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells
por: Tsaur, Igor, et al.
Publicado: (2015)

Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
por: Markowitsch, Sascha D., et al.
Publicado: (2022)

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
por: Tsaur, Igor, et al.
Publicado: (2015)

What should be the patient’s preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital
por: Mani, Jens, et al.
Publicado: (2016)

Outreach and Influence of Surgical Societies’ Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic—An Anonymized International Urologic Expert Inquiry
por: Boehm, Katharina, et al.
Publicado: (2020)

Pioneering Robotic Liver Surgery in Germany: First Experiences with Liver Malignancies
por: Croner, Roland S., et al.
Publicado: (2015)

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
por: Juengel, Eva, et al.
Publicado: (2013)

Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2021)

Impact of Blood Loss on Renal Function and Interaction with Ischemia Duration after Nephron-Sparing Surgery
por: Buse, Stephan, et al.
Publicado: (2022)

Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib
por: Juengel, Eva, et al.
Publicado: (2015)

SARS-CoV-2 outbreak in medical employees in a large urologic department: Spread, containment and outcome
por: Brandt, Maximilian Peter, et al.
Publicado: (2021)

Protein profile of basal prostate epithelial progenitor cells—stage‐specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo
por: Höfner, Thomas, et al.
Publicado: (2016)

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development
por: Schueler, Julia, et al.
Publicado: (2018)

Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2022)

Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells
por: Makarević, Jasmina, et al.
Publicado: (2014)

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2
por: Makarević, Jasmina, et al.
Publicado: (2014)

Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro
por: Makarević, Jasmina, et al.
Publicado: (2014)

HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
por: Juengel, Eva, et al.
Publicado: (2017)

Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro
por: Juengel, Eva, et al.
Publicado: (2019)

Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro
por: Tsaur, Igor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9qrbbatobeu0cmo90c1f40ujck